Catherine T. Doherty's Insider Trades & SAST Disclosures
Catherine T. Doherty's most recent trade in Quest Diagnostics, Inc. was a trade of 5,370 Common Stock done at an average price of $174.1 . Disclosure was reported to the exchange on March 5, 2025.
Add Superstar Alert
Note
This is a custom search result for pattern Catherine T. Doherty.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 174.13 per share. | 05 Mar 2025 | 5,370 | 68,068 (0%) | 0% | 174.1 | 935,078 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 173.74 per share. | 03 Mar 2025 | 10,380 | 78,448 (0%) | 0% | 173.7 | 1,803,421 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.74 per share. | 03 Mar 2025 | 5,010 | 73,438 (0%) | 0% | 173.7 | 870,437 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 175.79 per share. | 03 Mar 2025 | 716 | 68,068 (0%) | 0% | 175.8 | 125,866 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.74 per share. | 03 Mar 2025 | 394 | 68,784 (0%) | 0% | 173.7 | 68,454 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 172.61 per share. | 26 Feb 2025 | 824 | 69,178 (0%) | 0% | 172.6 | 142,231 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 171.75 per share. | 26 Feb 2025 | 455 | 70,002 (0%) | 0% | 171.7 | 78,146 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 170.99 per share. | 19 Feb 2025 | 899 | 70,457 (0%) | 0% | 171.0 | 153,720 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 169.71 per share. | 19 Feb 2025 | 535 | 71,356 (0%) | 0% | 169.7 | 90,795 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 13,344 | 13,344 | - | - | Non-Qualifed Stock Option (right to buy) | |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 3,479 | 71,891 (0%) | 0% | 0 | Common Stock | |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 33,103 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Exercise or conversion of derivative security received from the company (such as an option) at price $ 103.57 per share. | 27 Nov 2024 | 33,103 | 101,515 (0%) | 0% | 103.6 | 3,428,478 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 163.13 per share. | 27 Nov 2024 | 28,300 | 68,412 (0%) | 0% | 163.1 | 4,616,709 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 162.14 per share. | 27 Nov 2024 | 4,803 | 96,712 (0%) | 0% | 162.1 | 778,775 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 126.57 per share. | 28 Feb 2024 | 5,557 | 69,599 (0%) | 0% | 126.6 | 703,349 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 125.88 per share. | 28 Feb 2024 | 1,187 | 68,412 (0%) | 0% | 125.9 | 149,420 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.36 per share. | 28 Feb 2024 | 644 | 75,713 (0%) | 0% | 126.4 | 81,376 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | EVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.36 per share. | 28 Feb 2024 | 557 | 75,156 (0%) | 0% | 126.4 | 70,383 | Common Stock |
|
Quest Diagnostics, Inc.
|
T. Catherine Doherty | EVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 125.02 per share. | 23 Feb 2024 | 9,314 | 80,114 (0%) | 0% | 125.0 | 1,164,436 | Common Stock |
|
Quest Diagnostics, Inc.
|
Doherty Catherine T. | EVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.02 per share. | 23 Feb 2024 | 3,757 | 76,357 (0%) | 0% | 125.0 | 469,700 | Common Stock |
|
Quest Diagnostics, Inc.
|
T. Catherine Doherty | EVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 126.14 per share. | 21 Feb 2024 | 821 | 70,800 (0%) | 0% | 126.1 | 103,561 | Common Stock |
|
Quest Diagnostics, Inc.
|
T. Catherine Doherty | EVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.02 per share. | 21 Feb 2024 | 493 | 71,621 (0%) | 0% | 125.0 | 61,635 | Common Stock |
|
Quest Diagnostics, Inc.
|
Doherty T. Catherine | SVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 17,939 | 17,939 | - | - | Non-Qualifed Stock Option (right to buy) | |
|
Quest Diagnostics, Inc.
|
T. Doherty Catherine | SVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 4,304 | 72,114 (0%) | 0% | 0 | Common Stock | |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 147.86 per share. | 06 Mar 2023 | 9,917 | 77,727 (0%) | 0% | 147.9 | 1,466,328 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 140.55 per share. | 06 Mar 2023 | 5,307 | 67,810 (0%) | 0% | 140.6 | 745,899 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.86 per share. | 06 Mar 2023 | 4,610 | 73,117 (0%) | 0% | 147.9 | 681,635 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 140.63 per share. | 03 Mar 2023 | 717 | 67,810 (0%) | 0% | 140.6 | 100,832 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 140.69 per share. | 01 Mar 2023 | 392 | 68,527 (0%) | 0% | 140.7 | 55,150 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 15,167 | 15,167 | - | - | Non-Qualifed Stock Option (right to buy) | |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Regional Businesses | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 3,838 | 70,609 (0%) | 0% | 0 | Common Stock | |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 141.42 per share. | 23 Feb 2023 | 1,690 | 68,919 (0%) | 0% | 141.4 | 239,000 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Regional Businesses | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.86 per share. | 23 Feb 2023 | 962 | 66,771 (0%) | 0% | 147.9 | 142,241 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Regional Businesses | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2022 | 40,765 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Regional Businesses | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.63 per share. | 28 Nov 2022 | 40,765 | 108,498 (0%) | 0% | 86.6 | 3,531,472 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 149.37 per share. | 28 Nov 2022 | 23,407 | 67,733 (0%) | 0% | 149.4 | 3,496,390 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Regional Businesses | Sale of securities on an exchange or to another person at price $ 148.92 per share. | 28 Nov 2022 | 17,358 | 91,140 (0%) | 0% | 148.9 | 2,584,872 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Grant, award, or other acquisition of securities at price $ 130.09 per share. | 07 Mar 2022 | 13,392 | 81,125 (0%) | 0% | 130.1 | 1,742,165 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sale of securities on an exchange or to another person at price $ 135.21 per share. | 07 Mar 2022 | 7,032 | 67,733 (0%) | 0% | 135.2 | 950,797 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.09 per share. | 07 Mar 2022 | 6,360 | 74,765 (0%) | 0% | 130.1 | 827,372 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 16,155 | 16,155 | - | - | Non-Qualifed Stock Option (right to buy) | |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 3,328 | 67,733 (0%) | 0% | 0 | Common Stock | |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sale of securities on an exchange or to another person at price $ 126.26 per share. | 24 Feb 2022 | 2,750 | 64,405 (0%) | 0% | 126.3 | 347,215 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.09 per share. | 23 Feb 2022 | 1,082 | 67,647 (0%) | 0% | 130.1 | 140,757 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.23 per share. | 23 Feb 2022 | 492 | 67,155 (0%) | 0% | 130.2 | 64,073 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 95.79 per share. | 29 Nov 2021 | 37,565 | 106,294 (0%) | 0% | 95.8 | 3,598,539 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2021 | 37,565 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sale of securities on an exchange or to another person at price $ 156.85 per share. | 29 Nov 2021 | 15,908 | 83,304 (0%) | 0% | 156.9 | 2,495,249 | Common Stock |
|
Quest Diagnostics, Inc.
|
Catherine T. Doherty | SVP, Group Exec. Clin. Fran. | Sale of securities on an exchange or to another person at price $ 157.53 per share. | 29 Nov 2021 | 14,575 | 68,729 (0%) | 0% | 157.5 | 2,296,043 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges